Acamprosate Calcium
- Product NDC
- 50268-028
- 11-digit product format
- 502680028
- Labeler code
- 50268
- Product ID
- 50268-028_5ebfa8c9-acbb-b77e-e063-6294a90ab712
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acamprosate Calcium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA219904
- Marketing category
- ANDA
- Marketing start
- 2026-10-26
- Substance
- ACAMPROSATE CALCIUM
- Active strength
- 333 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219904-001 | ACAMPROSATE CALCIUM | ACAMPROSATE CALCIUM | 333MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-09-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219904-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A219904-001 | ACAMPROSATE CALCIUM | 333MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-09-18 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A219904-001 | ACAMPROSATE CALCIUM | 333MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-09-18 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A219904-001 | ACAMPROSATE CALCIUM | 333MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-09-18 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219904-001 | ACAMPROSATE CALCIUM | 333MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-09-18 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219904-001 | ACAMPROSATE CALCIUM | 333MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-09-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219904-001 | ACAMPROSATE CALCIUM | 333MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-09-18 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219904-001 | ACAMPROSATE CALCIUM | 333MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-09-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A219904-001 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A219904-001 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A219904-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219904-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A219904-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219904-001 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219904-001 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acamprosate Calcium
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACAMPROSATE CALCIUM | 333 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 59375N1D0U | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 835726 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5ebfa8c9-acba-b77e-e063-6294a90ab712 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acamprosate Calcium | ACAMPROSATE CALCIUM | AvPAK | 5ebfa8c9-acba-b77e-e063-6294a90ab712 | 2026-10-26 | Warnings, Adverse reactions | 219904 ANDA219904 50268-028 |
| Acamprosate Calcium | ACAMPROSATE CALCIUM | NCS HealthCare of KY, LLC dba Vangard Labs | 06b63fc8-572e-4b3d-8150-73b7854a9238 | 2026-09-17 | Warnings, Adverse reactions | 219904 ANDA219904 |
| Acamprosate Calcium | ACAMPROSATE CALCIUM | Bionpharma Inc., | 4473326f-79f1-61b2-e063-6294a90a17a3 | 2025-11-25 | Warnings, Adverse reactions | 219904 ANDA219904 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50268-028-13 | 50268002813 | 30 BLISTER PACK in 1 BOX (50268-028-13) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (50268-028-11) | 30 blister pack | 2026-10-26 | No | No | Current |